Inhibition of TXA2S with selective inhibitors induced apoptosis (via overproduction of ROS and reduction of NF-κB activity), confirming that it is indeed a potential therapy target in NSCLC [85,113]. Here, NFKB1 is linked to non-small cell lung carcinoma.